In 2025, Banner MD Anderson Cancer Center received Commission on Cancer accreditation and had over 160,000 clinic visits. The cancer center integrates the latest research, education and prevention using the same protocols and practice standards at MD Anderson Cancer Center in Houston. The evidence-based, multidisciplinary approach brings together 375 providers and other clinical experts from all cancer specialties at five Arizona and two Northern Colorado cancer center sites to provide treatment plans tailored to each patient’s unique cancer type and needs. Leading-edge therapies include CAR-T, bispecific antibody therapy, lymphedema surgery, intraperitoneal therapies, and nearly 100 clinical trials that explore new treatment modalities and therapies not widely available. It is among a few cancer centers with tumor-infiltrating lymphocyte cellular immunotherapy, using a patient’s immune cells to fight cancer, and histotripsy focused ultrasound to treat both malignant and benign liver tumors. In addition, holistic care addresses physical, emotional and psychological needs, as well as nutrition counseling, pain management and psychological support. In 2026, Phoenix-based Banner Health became the first hospital system in Arizona to launch the Tulsa PRO procedure for prostate cancer patients, a less invasive treatment option that uses high temperatures to destroy prostate cancer. It was also the first-in-state to offer robotic-assisted single-port nipple-sparing mastectomy for breast cancer patients. Robust community outreach and education programs raise awareness about prevention, screening and treatment. In 2026, Banner is celebrating a 15-year partnership with the University of Texas MD Anderson Cancer Center.
